Hannah Devlin speaks with Dr Ed Wild, from UCL, about Huntington’s and whether a new drug could slow its progression. And she hears from Roger, who was diagnosed with Huntington’s four years ago and his wife, Brenda.
Arabic language feature about the HTTRx trial program.
Huw Edwards discusses the IONIS-HTTRx trial success with Sarah Tabrizi and James Gallagher. Featuring footage of Ed Wild, Lauren Byrne and Filipe Brogueira Rodrigues.
Dr Ed Wild with Jenni Murray and HD family member Susan Fletcher, talk about Huntington’s disease on Woman’s Hour. Broadcast 15th July 2016.
Dr Ed Wild of UCL Huntington’s Disease Centre (Institute of Neurology) delivers an update on Ionis Pharmaceuticals 443139-CS1 trial, testing HTTRx, a huntingtin-lowering antisense oligonucleotide or ‘gene silencing’ drug in Huntington’s disease patients.
Dr Ed Wild and Dr Jeff Carroll present a live recording of their 2016 research update at the 2016 Huntington’s Disease Society of America Convention in Baltimore, entitled “The Best Time to Plant a Tree”, including updates on the Teva Pride-HD and Legato studies, Pfizer’s Amaryllis study, and Ionis Pharmaceuticals’ HTTRx ‘gene silencing’ trial.
Ed Wild talks at the 2015 CHDI Huntington’s Disease Therapeutics Conference in Palm Springs. Video by Ken Serbin / Gene Veritas.
Dr Ed Wild, of UCL Institute of Neurology and the National Hospital for Neurology and Neurosurgery, talks about his Huntington’s disease research. Recorded at the Leonard Wolfson Experimental Neurology Facility.
Dr Ed Wild and Dr Jeff Carroll talk about what’s new in Huntington’s disease research and why there is hope for tomorrow. Recorded live at the Huntington’s Disease Society of America Annual Convention 2014 in Louisville, Kentucky.